A long-acting synthetic counterpart of oxytocin, Carbetocin (CAS 37025-55-1) is widely used in veterinary and human medicine to treat and prevent postpartum problems. Its potent uterotonic effects support safer recovery following birth, reduce postpartum bleeding, and encourage efficient uterine contraction.

Product Description

CAS Number: 37025-55-1
Standard: In-house Standard
Product Name: Carbetocin API
Category: Long-acting Oxytocin Analog / Uterotonic Agent

Carbetocin binds strongly to uterine oxytocin receptors, mimicking natural oxytocin but with longer duration, higher stability, and improved clinical convenience.

Introduction to Carbetocin API

Carbetocin prevents excessive postpartum bleeding by activating oxytocin receptors with high affinity, effectively contracting the uterus after delivery and supporting its return to pre-pregnancy state.

How Carbetocin Works (Mechanism of Action)

Carbetocin binds to oxytocin receptors in uterine smooth muscle, triggering:

▸ Strong, coordinated uterine contractions

▸ Compression of uterine blood vessels

▸ Stabilization of postpartum bleeding

▸ Improved uterine involution

Its high receptor affinity and prolonged half-life make Carbetocin more reliable than oxytocin, especially when immediate and sustained uterine contraction is critical.

Advantages of Carbetocin

Clinical Applications of Carbetocin

▸ Prevention of postpartum hemorrhage (PPH)

▸ Management of uterine atony

▸ Post-delivery stabilization

▸ Support during cesarean sections and vaginal births

Safety Profiles and Side Effects

▸ Nausea or vomiting

▸ Headache

▸ Mild, transitory hypotension

▸ Abdominal pain

Why Carbetocin is in High Demand

▸ Long-term uterotonic impact

▸ Improved maternal safety

▸ Better outcomes than conventional oxytocin

▸ Reduced medical workload

▸ Ideal for low-resource settings